Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer

计划入组 36 人 · 首次发布于 2020 年 12 月 19 日

Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

计划入组 34 人 · 首次发布于 2020 年 12 月 9 日

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

计划入组 60 人 · 首次发布于 2025 年 7 月 10 日

Etoposide(Etopophos, Toposar, Vepesid)

C₂₉H₃₂O₁₃ · Rx

Platinum

Pt

Etoposide toniribate

C₃₆H₄₂O₁₇

Platinum Capital Ltd

Platinum Trident Enterprise LLC

United States

YUNNAN COPPER INDUSTRY CO.LTD

Genelux Case Report Details 16.7-Month PFS in Platinum-Relapsed SCLC After Systemic Olvi-Vec Plus Platinum Rechallenge

DeLLphi-305: Durvalumab Plus Tarlatamab Hits Overall Survival in First-Line ES-SCLC Maintenance

Etoposide Shortage Linked to Worse Outcomes in Small Cell Lung Cancer